Randall B. Brenner, Chief Development & Regulatory at Paratek Pharmaceuticals, Inc. (PRTK), sold 23,684 shares at $6.71 ($160K) on 2020-12-14, disclosed to the SEC on 2020-12-15.
Open-market sale of $160k PRTK by Chief Development & Regulatory. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.95 | 6,164 | $43K | 26.7% |
| 2 | $6.71 | 8,760 | $59K | 36.6% |
| 3 | $6.71 | 8,760 | $59K | 36.6% |
| Total | $6.77 avg | 23,684 | $160K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $58K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $12K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $104K | — | Filing → |